Biotechnology and pharmaceutical organizations face enormous pressures as they seek to bring new products to market. Competition requires accelerated drug discovery and product development, while federal regulations dictate finite windows of opportunities for maximizing their profits. Consequently, the time required for designing, building, renovating, and managing capital projects and facilities that are essential to delivering new products directly affects a company's top-line growth and profitability. Delays in facility completion and startup can mean millions of dollars in lost revenue. Design requires complex coordination of disciplines to build a facility that can be readily validated, is efficient to operate and maintain, and meets the owner's campus/community master plan, R&D and manufacturing requirements. Strict regulatory standards require extremely detailed design, construction, and validation processes, all of which must be supported by thorough documentation, installation, operation and performance qualification controls.

Unifier™ for Life Sciences

Skire's unparalleled experience with design-construction and IT projects has resulted in Skire Unifier™-the industry's leading capital program, capital project, real estate, facilities, and IT portfolio management solution. Unifier™ solutions optimize and automate business processes and integrate the flow of information and communications between project team members for improved productivity and accelerated time to market. Unifier™ enables pharmaceutical capital projects to be completed on schedule through rapid collaboration and increased visibility-and on budget with strong cost controls and real-time change management and cost reporting. All while providing a detailed record of transactions for future risk mitigation, TOP preparation and facility validation.

One of the world's leading biotechnology companies in the world selected Skire.